USA2 SPOTLIGHT

A November 28, 2017 Inside Sources opinion piece by Rita Altman of Sunrise Senior Living posits that it’s time for everyone to get involved in the fight against Alzheimer’s disease. According to UsAgainstAlzheimer’s Co-Founder and Chairman George Vradenburg, “The earlier we detect a disease, the better our chances are of stopping it and curing it. With the XPRIZE we will employ global crowdsourcing and harness emerging technologies to unleash a new era of interventions that would have the best chance of saving millions of lives.”

MUST READS

A November 29, 2017 Alzheimer’s News Today article reported that LMTX, an experimental Alzheimer’s disease treatment, may slow cognitive decline in patients at low doses but only when used without any other AD drug. For patients on LMTX monotherapy, researchers found improved measures of cognitive decline, slowed rate of brain tissue wasting to rates seen in healthy older adults, and improved brain blood glucose use. According to George Perry of the University of Texas at San Antonio and Journal of Alzheimer’s Disease, “These highly significant results support further validation of tau-based therapy in Alzheimer’s disease.”

MUST WATCH

A November 29, 2017 (NBC) 3 News Las Vegas video segment interviewed Patti Davis, daughter of President Ronald Reagan, who was diagnosed with Alzheimer’s disease in 1994. She started Beyond Alzheimer’s, a support group for caregivers. According to Davis, “I call it Beyond Alzheimer’s because I want to instill in people looking beyond the disease. There is a soul inside that I don’t believe can be sick.”

A November 27, 2017 Spectrum News video segment spotlighted Lorri Doe, who is caring for her 82-year old dad with dementia. According to Doe, “I’m not the first person to have to do this.  Other people have done this before me so there’s got to be someone I can talk to or learn from.”  

MUST LISTEN

In a November 29, 2017 Financial Times audio segment, Science Editor Clive Cookson explores the long and difficult journey of scientists researching dementia and looking for a cure.